Affinity Asset Advisors »

Adagio Med Hldgs shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Adagio Med Hldgs (ADGM) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Adagio Med Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Adagio Med Hldgs held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Med Hldgs by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $224k 213k 1.05
2024-09-30 $550k 213k 2.58

More positions owned by Affinity Asset Advisors

Spdr Ser Tr S&p Biotech Put Option (XBI)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Verona Pharma Sponsored Ads (VRNA)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nuvalent Inc-a (NUVL)
Spyre Therapeutics Com New (SYRE)
Wave Life Sciences SHS (WVE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Vera Therapeutics Cl A (VERA)
Nurix Therapeutics (NRIX)

View all positions for Affinity Asset Advisors

Top funds holding Adagio Med Hldgs

Perceptive Advisors
Affinity Asset Advisors
Rtw Investments
Shaolin Capital Management
ADAR1 Capital Management
Opaleye Management
Jpmorgan Chase & Co
Geode Capital Management
XTX Topco
Toronto-Dominion Bank
Virtu Financial
Tower Research Capital
UBS Group
Bank of America Corporation
SBI Securities

View all funds holding Adagio Med Hldgs